Ş Apraş

568 total citations
21 papers, 446 citations indexed

About

Ş Apraş is a scholar working on Rheumatology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ş Apraş has authored 21 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Rheumatology, 5 papers in Immunology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ş Apraş's work include Systemic Lupus Erythematosus Research (7 papers), Spondyloarthritis Studies and Treatments (3 papers) and Inflammasome and immune disorders (3 papers). Ş Apraş is often cited by papers focused on Systemic Lupus Erythematosus Research (7 papers), Spondyloarthritis Studies and Treatments (3 papers) and Inflammasome and immune disorders (3 papers). Ş Apraş collaborates with scholars based in Türkiye. Ş Apraş's co-authors include Meral Çalgünerı, İhsan Ertenli, Sedat Kiraz, Zeynep Özbalkan, Zafer Çalışkaner, Ömer Karadağ, Ali Akdoğan, Umut Kalyoncu, Suzan Özer and İbrahim C. Haznedaroğlu and has published in prestigious journals such as Annals of the Rheumatic Diseases, The American Journal of the Medical Sciences and Lupus.

In The Last Decade

Ş Apraş

21 papers receiving 425 citations

Peers

Ş Apraş

RHEUM

PFM

IMMUN

HEMAT

Ritva Peltomaa Finland

Arzu Kaya Türkiye

Oscar‐Danilo Ortega‐Hernandez Israel

Elena López‐Isac Spain

Maria Konsta Greece

K. Helmke Germany

Giuseppe Marotta Italy

Laura Willis United States

Debbie Allan United Kingdom

Dèlia Reina Spain

Ritva Peltomaa Finland

Ş Apraş

345 ×1.7

RHEUM

54 ×0.5

PFM

93 ×0.9

IMMUN

122 ×1.2

HEMAT

74 ×0.9

Citations per year, relative to Ş Apraş Ş Apraş (= 1×) peers Ritva Peltomaa

Countries citing papers authored by Ş Apraş

Since Specialization

Citations

This map shows the geographic impact of Ş Apraş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ş Apraş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ş Apraş more than expected).

Fields of papers citing papers by Ş Apraş

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ş Apraş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ş Apraş. The network helps show where Ş Apraş may publish in the future.

Co-authorship network of co-authors of Ş Apraş

This figure shows the co-authorship network connecting the top 25 collaborators of Ş Apraş. A scholar is included among the top collaborators of Ş Apraş based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ş Apraş. Ş Apraş is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Akar, Servet, Bünyamin Kısacık, Ş Apraş, et al.. (2014). THU0072 Comparison of Characteristics of Ankylosing Spondylitis in Association with Familial Mediterranean Fever with Those of Typical Ankylosing Spondylitis. Annals of the Rheumatic Diseases. 73. 201–202. 2 indexed citations

Ertenli, İhsan, Suzan Özer, Sedat Kiraz, et al.. (2010). Infliximab, a TNF-alpha antagonist treatment in patients with ankylosing spondylitis: the impact on depression, anxiety and quality of life level. Rheumatology International. 32(2). 323–330. 98 indexed citations

Aksoy, Duygu Yazgan, Kemal Ağbaht, Özgür Harmancı, et al.. (2008). Autoimmune Polyendocrine Syndrome With Atrial Septal Defect. The American Journal of the Medical Sciences. 335(2). 157–159. 2 indexed citations

Çalgünerı, Meral, Zeynep Özbalkan, Mehmet Akif Öztürk, et al.. (2006). Intensified, intermittent, low-dose intravenous cyclophosphamide together with oral alternate-day steroid therapy in lupus nephritis (long-term outcome). Clinical Rheumatology. 25(6). 782–788. 8 indexed citations

Özbalkan, Zeynep, et al.. (2005). Wegener's granulomatosis: clinical and laboratory results of a university hospital study of 20 patients from Turkey. Clinical Rheumatology. 25(3). 358–363. 6 indexed citations

Üreten, Kemal, İhsan Ertenli, Mumin Ozturk, et al.. (2005). Neutrophil CD64 expression in Behçet's disease.. PubMed. 32(5). 849–52. 25 indexed citations

Çalgünerı, Meral, et al.. (2004). The efficacy of continuous interferon alpha administration as an adjunctive agent to colchicine-resistant familial Mediterranean fever patients.. PubMed. 22(4 Suppl 34). S41–4. 23 indexed citations

Çobankara, Veli, Düzgün Özatlı, Sedat Kiraz, et al.. (2004). Successful treatment of rheumatoid arthritis is associated with a reduction in serum sE-selectin and thrombomodulin level. Clinical Rheumatology. 23(5). 430–434. 14 indexed citations

Apraş, Ş, Rengin Elsürer, Meral Çalgünerı, et al.. (2004). Massive Deep Venous Thrombosis and Venous Gangrene in a 29-year-old Case: Metastatic Epidermoid Carcinoma with an Unknown Primary. Hematology. 9(4). 297–300. 1 indexed citations

10.

Çalgünerı, Meral, et al.. (2004). The Efficacy of Interferon-alpha in a Patient with Resistant Familial Mediterranean Fever Complicated by Polyarteritis Nodosa. Internal Medicine. 43(7). 612–614. 14 indexed citations

11.

Çalgünerı, Meral, et al.. (2004). Combination therapies in spondyloarthropathies.. PubMed. 50(1-2). 31–7. 6 indexed citations

12.

Çalgünerı, Meral, Ş Apraş, Zeynep Özbalkan, et al.. (2003). The efficacy of oral cyclophosphamide plus prednisolone in early diffuse systemic sclerosis. Clinical Rheumatology. 22(4-5). 289–294. 26 indexed citations

13.

Apraş, Ş, İhsan Ertenli, Zeynep Özbalkan, et al.. (2003). Effects of oral cyclophosphamide and prednisolone therapy on the endothelial functions and clinical findings in patients with early diffuse systemic sclerosis. Arthritis & Rheumatism. 48(8). 2256–2261. 62 indexed citations

14.

Çalgünerı, Meral, Veli Çobankara, Düzgün Özatlı, et al.. (2003). Is Visual Loss Due to Giant Cell Arteritis Reversible?. Yonsei Medical Journal. 44(1). 155–155. 4 indexed citations

15.

Göker, Hakan, Sema Karakuş, İbrahim C. Haznedaroğlu, et al.. (2002). Plasma Thrombopoietin in Patients With Cavernous Transformation of the Portal Vein. International Journal of Hematology. 75(1). 91–94. 1 indexed citations

16.

Yı́ldı́rı́r, Aylin, Serdar Aksöyek, Meral Çalgünerı, et al.. (2001). No Evidence of Cardiac Autonomic Involvement in Ankylosing Spondylitis, as Assessed by Heart Rate Variability. Clinical Rheumatology. 20(3). 185–188. 13 indexed citations

17.

Çobankara, Veli, et al.. (2001). AB0079 Cyclophosphamide exposure during pregnancy: two cases. Annals of the Rheumatic Diseases. 60. A53–A53. 1 indexed citations

18.

Pay, S., Meral Çalgünerı, Zafer Çalışkaner, et al.. (2000). Evaluation of vascular injury with proinflammatory cytokines, thrombomodulin and fibronectin in patients with primary fibromyalgia.. PubMed. 63(3-4). 115–22. 16 indexed citations

19.

Çalgünerı, Meral, et al.. (2000). Combination therapy versus monotherapy for the treatment of patients with rheumatoid arthritis.. PubMed. 17(6). 699–704. 96 indexed citations

20.

Kiraz, Sedat, İhsan Ertenli, Mustafa Beneklı, et al.. (1999). Clinical significance of hemostatic markers and thrombomodulin in systemic lupus erythematosus: evidence for a prothrombotic state. Lupus. 8(9). 737–741. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact